Related references
Note: Only part of the references are listed.Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer
Shu-Fu Lin et al.
CLINICAL CANCER RESEARCH (2008)
Herpes simplex virus Us3(-) mutant as oncolytic strategy and synergizes with phosphatidylinositol 3-kinase-akt-targeting molecular therapeutics
Ta-Chiang Liu et al.
CLINICAL CANCER RESEARCH (2007)
Systemic oncolytic herpes virus therapy of poorly immunogenic prostate cancer metastatic to lung
S Varghese et al.
CLINICAL CANCER RESEARCH (2006)
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers
S Varghese et al.
CANCER GENE THERAPY (2006)
Oncolytic herpes simplex virus vector G47Δ in combination with androgen ablation for the treatment of human prostate adenocarcinoma
H Fukuhara et al.
CLINICAL CANCER RESEARCH (2005)
5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer
DP Eisenberg et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage
WK Tao et al.
CANCER CELL (2005)
Cell death by mitotic catastrophe: a molecular definition
M Castedo et al.
ONCOGENE (2004)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Replicative oncolytic herpes simplex viruses in combination cancer therapies
DE Post et al.
CURRENT GENE THERAPY (2004)
Stuck in division or passing through: What happens when cells cannot satisfy the spindle assembly checkpoint
CL Rieder et al.
DEVELOPMENTAL CELL (2004)
Herpes simplex virus gene products required for viral inhibition of expression of G1-phase functions
BW Song et al.
VIROLOGY (2001)
Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus
H Petrowsky et al.
JOURNAL OF VIROLOGY (2001)
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
T Todo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates
S Varghese et al.
HUMAN GENE THERAPY (2001)
Herpes simplex virus type 1 infection imposes a G1/S block in asynchronously growing cells and prevents G1 entry in quiescent cells
GL Ehmann et al.
VIROLOGY (2000)
Share Paper
